At 12 months post-index, 1.0 mg was the most common dosage formulation (59%), followed by 0.5 mg (39%)
Duration depends on the condition being treated, individual recovery, and the recommendations of the healthcare provider supervising therapy
If the solution looks the same as always, the issue is probably not medication degradation
Blood sugar spikes after meals are blunted, supporting better glycemic control
Direct comparison meta-analysis When researchers pooled data from comparable studies, retatrutide produced an average of 16.34 kg of weight loss compared to 11.82 kg for tirzepatide
Improves Immunity : Boosts immune system function, contributing to overall skin health